Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery

Clinical trial NCT01947023 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT01947023

Sponsor

National Cancer Institute (NCI)

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2013-09-27

Primary completion

2026-04-29

Enrollment

23

View on ClinicalTrials.gov